Skip to main content

Taking another stab at Braille

There’s been a raging online debate going on among some of the online communities for people with albinism about whether children with albinism should be taught Braille.

I do hope to blog about that topic later – I just don’t have the energy for it now.

I will say that I very much wish I’d had the opportunity as a child. I wasn’t introduced to Braille until adulthood. I learned both grades 1 and 2 Braille in about six weeks at the Louisiana Center for the Blind. Learning the code is the easy part though. It’s building the speed that takes time and can be done through nothing but sheer practice.

I did use Braille my freshman year of college, but then got sick. At the time I didn’t know I had HPS – only that I was constantly sick and very fatigued. Because my speed wasn’t quite up to my print speed, I abandoned it. Had I been able to keep it up just a few months more I think I would have nailed it down.

Later in college I took Braille lessons again. The problem was I knew the code. I didn’t need lessons. I needed time to practice and it was hard to come by.
I dream of being able to read a book myself, not through an audio book, and be able to read and read until I feel like stopping – not because I’m getting a headache or am tired of holding a magnifier or sitting in some strange position – but because I just want to stop.

I don’t read as much as I’d like. And now that I have some flexibility, I feel I can revisit this issue and try again.

Wish me luck!

Comments

Unknown said…
I'm actually about to start learning Braille! I'm taking a course through the Hadley school for the Blind. Can't wait - it's something I've been meaning to do for a while, and now I've got the time. :) Wish me luck! I can only recognize certain letters and that's it. Got any tips for learning?

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria